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Abstract
Hepatitis B virus (HBV) genome is organized into a minichromosome known as covalently closed circular DNA
(cccDNA), which serves as the template for all viral transcripts. SIRT1 is an NAD+-dependent protein deacetylase
which activates HBV transcription by promoting the activity of cellular transcription factors and coactivators. How
SIRT1 and viral transactivator X protein (HBx) might affect each other remains to be clarified. In this study we show
synergy and mutual dependence between SIRT1 and HBx in the activation of HBV transcription. All human sirtuins
SIRT1 through SIRT7 activated HBV gene expression. The steady-state levels of SIRT1 protein were elevated in HBV-
infected liver tissues and HBV-replicating hepatoma cells. SIRT1 interacted with HBx and potentiated HBx
transcriptional activity on precore promoter and covalently closed circular DNA (cccDNA) likely through a deacetylase-
independent mechanism, leading to more robust production of cccDNA, pregenomic RNA and surface antigen. SIRT1
and HBx proteins were more abundant when both were expressed. SIRT1 promoted the recruitment of HBx as well as
cellular transcriptional factors and coactivators such as PGC-1α and FXRα to cccDNA. Depletion of SIRT1 suppressed
HBx recruitment. On the other hand, SIRT1 recruitment to cccDNA was compromised when HBx was deficient.
Whereas pharmaceutical agonists of SIRT1 such as resveratrol activated HBV transcription, small-molecule inhibitors
of SIRT1 including sirtinol and Ex527 exhibited anti-HBV activity. Taken together, our findings revealed not only the
interplay between SIRT1 and HBx in the activation of HBV transcription but also new strategies and compounds for
developing antivirals against HBV.
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1 Figure legends
2 Fig. 1. All mammalian sirtuins positively regulated HBV transcription. (A) Verification 
3 of the expression of FLAG-tagged sirtuins in HepG2-NTCP cells. (B) cccDNA levels 
4 in sirtuin-expressing cells. HepG2-NTCP cells were transfected with pHBV1.3D and 
5 sirtuin plasmids. Cells were harvested 48 h post-transfection. Nuclear DNA was 
6 isolated and treated sequentially with SacI restriction endonuclease and plasmid-safe 
7 ATP-dependent DNase. Treated fraction was analyzed for cccDNA by qPCR. GAPDH 
8 transcript was amplified from untreated cytoplasmic fraction for normalization. Results 
9 are representation of three independent experiments and error bars indicate SD. The 
10 difference between control and SIRT7 groups is statistically significant (p = 0.014). 
11 N.D.: not detected. (C) pgRNA levels in sirtuin-expressing cells. Total RNA was 
12 extracted and cDNA was synthesized. RT-qPCR was performed to analyze the relative 
13 levels of pgRNA. The difference between control and SIRT7 groups is statistically 
14 significant (p = 0.024). (D) Levels of extracellular HBsAg in sirtuin-expressing cells. 
15 Culture media were centrifuged to remove debris and HBsAg was assayed by ELISA. 
16 Relative HBsAg level in cells transfected with pHBV1.3D alone was taken as 1. The 
17 differences between control and SIRT6 groups is statistically significant (p = 0.0033). 
18
19 Fig. 2. Elevation of SIRT1 protein expression in HBV-infected human liver tissues and 
20 HBV-replicating HepG2-NTCP cells. (A) Steady-state levels of SIRT1 protein in HBV- 
21 and HBV+ human liver tissues. Western blotting was performed with rabbit anti-SIRT1 
22 and mouse anti-β-actin antibodies. (B) Steady-state levels of SIRT1 protein in HepG2-
23 NTCP cells transfected with increasing amounts of pHBV1.3D and in HepG2.2.15 
24 cells. Cells were harvested 48 h post-transfection for Western blot analysis. 
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1 Fig. 3. SIRT1 augmented HBx-induced activation of HBV transcription. (A, B) Levels 
2 of pgRNA and extracellular HBsAg in HBV-infected cells. HepG2-NTCP cells were 
3 infected with HBV at a multiplicity of genome equivalents of 100. After 6 days cells 
4 were co-transfected with expression plasmids for SIRT1 and HBx for another 2 days. 
5 pgRNA was analyzed by RT-qPCR (A). Culture media were centrifuged to remove 
6 debris and HBsAg was assayed by ELISA (B). Relative pgRNA or HBsAg level in cells 
7 infected with HBV alone was taken as 1. The differences between bars 2 and 3 (p = 
8 0.008656 for panel A and p = 0.000079 for panel B) as well as between bars 3 and 5 (p 
9 = 0.0395 for panel A and p = 0.000414 for panel B) are statistically significant. N.D.: 
10 not detected. (C, D) cccDNA levels in transfected cells. Cells were co-transfected with 
11 pHBV1.3D (C) or its HBx-deficient mutant pHBV-X- (D) and expressing plasmid for 
12 SIRT1 wild-type (WT) or its H363Y. Either HBx or PGC-1α was also expressed. The 
13 differences between bars 2 and 3 (p = 0.0053) and between bars 5 and 7 (p = 0.0013) 
14 in panel C as well as between bars 6 and 8 in panel D (p = 0.013) are statistically 
15 significant. The differences between bars 2 and 4 (p = 0.34) and between bars 8 and 10 
16 (p = 0.73) in panel C are statistically not significant (n.s.). (E, F) pgRNA levels in 
17 transfected cells. The differences between bars 2 and 3 (p = 0.0044) and between bars 
18 5 and 7 (p = 0.00006) in panel E as well as between bars 6 and 8 in panel F (p = 0.0015) 
19 are statistically significant. The differences between bars 2 and 4 (p = 0.30) and between 
20 bars 8 and 10 (p = 0.27) in panel E are statistically not significant (n.s.). (G) Levels of 
21 extracellular HBsAg in transfected cells. The differences between bars 2 and 3 (p = 
22 0.000019) and between bars 5 and 7 (p = 0.000018) are statistically significant. The 
23 differences between bars 2 and 4 (p = 0.074) and between bars 8 and 10 (p = 0.10) are 
24 statistically not significant (n.s.). (H, I) SIRT1 and HBx mRNA levels. Cells were 
25 harvested 48 h post-transfection for RT-qPCR analysis. The differences between bars 
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1 1 and 2 (p = 0.00003) and between bars 4 and 5 (p = 0.00014) in panel H are statistically 
2 significant. The differences between bars 1 and 2 (p = 0.41) and between bars 4 and 5 
3 (p = 0.07) are statistically not significant (n.s.). (J) Activation of HBV preC promoter. 
4 HepG2-NTCP cells transfected with the indicated plasmids were harvested at 36 h after 
5 transfection. Dual luciferase assays were performed. The luciferase activity was 
6 normalized to RLuc readings and expressed as fold activation. The difference between 
7 bars 1 and 2 (p = 0.046) is statistically significant. (K) SIRT1 recruitment to preC 
8 promoter. ChIP was performed with rabbit anti-SIRT1 and the preC promoter-specific 
9 sequence was analyzed by qPCR. Results represent relative recruitment measured in 
10 arbitrary units (AU). The difference between bars 2 and 3 (p = 0.000087) is statistically 
11 significant. N.D.: not detected.
12
13 Fig. 4. SIRT1 facilitated recruitment of HBx, PGC-1α and FXRα to cccDNA. HepG2-
14 NTCP cells were co-transfected with pHBV1.3D and expression plasmid for FLAG-
15 SIRT1 for 48 h. ChIP was performed to precipitate SIRT1-, HBx-, PGC-1α- and FXRα-
16 bound DNA complex using anti-FLAG (A), anti-HBx (B), anti-PGC-1α (C) and anti-
17 FXRα (D). The differences between bars 2 and 3 are statistically significant (A: p = 
18 0.0011; B: p = 0.0018; C: p = 0.0006; D: p = 0.0018). N.D.: not detected. 
19
20 Fig. 5. Depleting SIRT1 suppressed HBV transcription and HBx recruitment to 
21 cccDNA. (A) Depletion of endogenous SIRT1 in HepG2-NTCP cells and HepG2.2.15 
22 cells by siRNAs. Cells were transfected with two independent SIRT1-targting siRNAs 
23 (siSIRT1-a and siSIRT1-b) or siNC (negative control) at a concentration of 100 nM for 
24 48 h. The transfection efficiency of siRNAs was estimated to be 75%. Western blotting 
25 was performed with rabbit anti-SIRT1 and mouse anti-β-actin antibodies. (B) Decrease 
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1 of cccDNA levels in SIRT1-depleted HepG2.2.15 cells. The difference between bars 1 
2 and 2 (p = 0.049) is statistically significant. (C) Knockdown of SIRT1 suppressed 
3 pgRNA expression in pHBV1.3D-transfected HepG2-NTCP cells. The difference 
4 between bars 2 and 4 (p = 0.0065) is statistically significant. (D-F) Depletion of SIRT1 
5 perturbed HBx, PGC-1α and FXRα recruitment to cccDNA. HepG2.2.15 cells were 
6 transfected with the indicated siRNAs for 48 h. The differences between bars 1 and 3 
7 are statistically significant(D: p = 0.0002; E: P = 0.00003; F: p = 0.000015).
8
9 Fig. 6. Functional interplay between SIRT1 and HBx. (A) Co-immunoprecipitation of 
10 SIRT1 and HBx from HepG2-NTCP cells. Cells were co-transfected with the indicated 
11 expression plasmids and harvested at 48 h after transfection. Immunoprecipitation (IP) 
12 was performed with anti-HA. Precipitates and input (5%) were analyzed by Western 
13 blotting with mouse anti-FLAG, mouse anti-HA, mouse anti-β-actin and rabbit anti-
14 AcK. Bands for immunoglobulin heavy and light chains are indicated by “#” and “Δ”, 
15 respectively. (B) Abundance of SIRT1 and HBx proteins when they were co-expressed. 
16 Western blotting was performed with mouse anti-FLAG, anti-HA and anti-β-actin. (C) 
17 HBx protein expression in HepG2-NTCP cells transfected with pHBV1.3D and SIRT1 
18 expression plasmid. (D) SIRT1 protein expression in HepG2-NTCP cells transfected 
19 with pHBV1.3D (pHBV-WT) or its HBx-deficient mutant pHBV-X-. Western blotting 
20 was performed with rabbit anti-SIRT1, rabbit anti-HBx and mouse anti-β-actin. (E, F) 
21 Loss of HBx suppressed the SIRT1 recruitment to cccDNA and preC promoter. HepG2-
22 NTCP cells were co-transfected with the indicated plasmids. ChIP was performed to 
23 precipitate SIRT1-DNA complex. The differences between bars 2 and 3 are statistically 
24 significant, with P values equal to 0.0087 (E) and 0.0039 (F), respectively.
25
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1 Fig. 7. Influence of SIRT1 modulators on HBV transcription. (A) Decline of cccDNA 
2 levels in HepG2.2.15 cells treated with SIRT1 inhibitors (SIRT1i). HepG2.2.15 cells 
3 were treated with increasing doses (25, 50 and 75 μM) of sirtinol and Ex527 for 36 h. 
4 The difference between bars 2 and 4 is statistically significant (p = 0.018). (B) Decline 
5 of pgRNA expression in HepG2.2.15 cells treated with SIRT1i. The difference between 
6 bars 2 and 4 is statistically significant (p = 0.0036). (C) Time course of HBsAg 
7 detection in culture media of HBV-infected HepG2-NTCP cells treated with SIRT1i. 
8 HepG2-NTCP cells were infected with HBV at a multiplicity of genome equivalents of 
9 100.  After 8 days cells were treated with 50 μM of sirtinol or Ex527 for 48 h. Culture 
10 supernatants were collected every 12 h for ELISA analysis of HBsAg. The differences 
11 between DMSO and Sirtinol groups (p = 0.0045) and between DMSO and Ex527 
12 groups (p = 0.041) are statistically significant. (D) Elevation of cccDNA levels in HBV-
13 infected HepG2-NTCP cells treated with 25, 50 and 75 μM of resveratrol (Res). 
14 Difference between bars 2 and 3 is statistically significant (p = 0.0081). (E) Increased 
15 pgRNA levels in HBV-infected HepG2-NTCP cells treated with resveratrol (Res). The 
16 difference between bars 2 and 3 is statistically significant (p = 0.0013).
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Supplementary material
Fig. S1. cccDNA detection in pHBV1.3D-transfected HepG2-NTCP cells. Cells were 
transfected with pHBV1.3D or its disrupted version pHBV1.3D-d1 and harvested 48 h 
after transfection for cccDNA detection by RT-qPCR. (A) Isolated nuclear DNA (200 
ng) was digested with XbaI restriction enzyme (5 µl) or increasing amounts of SacI 
restriction enzyme (1, 2 and 5 µl) for 2 h at 37 oC and subsequently with plasmid-safe 
ATP-dependent DNase (PSAD). Whereas XbaI cuts the HBV genome at one single site 
so that no cccDNA can be formed, there is only one single SacI site outside of the HBV 
genome in pHBV1.3D. (B) Isolated nuclear DNA (200 ng) was digested with SacI (2 
µl) for 1, 3, 6 and 12 h at 37 oC and subsequently with PSAD. (C) Isolated nuclear DNA 
(200 ng) was digested with SacI (2 µl) for 6 h at 37 oC and subsequently with PSAD. 
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Fig. S2. mRNA levels of all sirtuins (SIRT1 to SIRT7) in pHBV1.3D-transfected 
HepG2-NTCP cells and in HepG2.2.15 cells. Cells were harvested 48 h post-
transfection for RT-qPCR analysis. 
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8 Highlights:
9  All sirtuins activate HBV transcription.
10  SIRT1 interacts with HBx and potentiates HBx activity.
11  SIRT1 and HBx are mutually dependent in the activation of HBV transcription.
12  SIRT1 inhibitors have anti-HBV activity.











